Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas

Oncogene

Volumn 18, Issue 46, 1999, Pages 6370-6379

  Balañá, Maria Eugenia ^a   Lupu, Ruth ^b   Labriola, Leticia ^a   Charreau, Eduardo H ^a   Elizalde, Patricia V ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heregulin; Mouse mammary tumors; Progestin; Type I insulin like growth factor receptor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST ADENOCARCINOMA; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HORMONAL CARCINOGENESIS; MITOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033524018     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203028     Document Type: Article

References (43)

1. Amundadottir LT and Leder P. (1998). Oncogene, 16, 737-746.
2. Backer JM, Myers MG, Sun XJ, Chen DJ, Schoelson SE, Mivalpeix M and White MF. (1993). J. Biol. Chem., 268, 8204-8212.
3. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski H, Peles E, Ben-Baruch N, Farbstein H, Lupu R, Wen D, Sela M and Yarden Y. (1993). Cancer Res., 53, 5251-5261.
4. Barone MV and Courtneidge SA. (1995). Nature. 378, 509-512.
5. Berlii R, Graus Porta D, Woods-Cook K, Chen X, Yarden Y and Hynes NE. (1995). Mol. Cell. Biol., 15, 6496-6505.
6. Carraway KL and Cantley LC. (1994). Cell, 78, 5-8.
7. Chomczysnki P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
8. Colomer R, Lupu R, Bacus SS and Gelmann EP. (1994). Br. J. Cancer, 70, 819-825.
9. Coppola D, Ferber A, Masahiko M, Sell C, D'Ambrosio C, Rubin R and Baserga R. (1994). Mol. Cell. Biol., 14, 4588-4595.
10. Culouscou JM, Plowman GD, Carlton GW, Green JM and Shoyab M. (1993). J. Biol. Chem., 268, 18407-18410.
11. Dran G, Luthy IA, Molinolo AA, Montecehia F, Charreau EH, Dosne Pasqualini C and Lanari C. (1995). Breast Cancer Res. Treat., 35, 173-186.
12. Elizalde PV, Lanari C, Molinolo AA, Guerra FK, Balañá ME, Simian M, Iribarren AM, Charreau EH. (1998). J. Steroid Biochem. Mol. Biol. 67, 305-317.
13. Fedi P, Pierce J, Di Fiore PP and Kraus M. (1994). Mol. Cell. Biol., 14, 492-500.
14. Graus-Porta D, Beerli RR and Hynes NE. (1995). Mol. Cell. Biol., 15, 1182-1191.
15. Graus-Porta D, Beerli RR, Daly JM and Hynes NE. (1997). EMBO J., 16, 1647-1655.
16. Grunt TW, Saceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H and Dittrich C. (1995). Int. J. Cancer, 63, 560-567.
17. Guerra FK, Eijan AM, Puricelli L, Alonso DF, Bal de Kier Joffé E, Kornblihtt AR, Charreau EH and Elizalde PV. (1996). Int. J. Cancer, 65, 812-820.
18. Hamburger AW and Yoo JY. (1997). Mol. Cell. Endocrinol., 138, 163-171.
19. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard M, Wood WI, Goeddel DV and Vandlen RL. (1992). Science. 256, 1205-1210.
20. Krane IM and Leder P. (1996). Oncogene, 12, 1781-1788.
21. Lanari C, Kordon E, Molinolo AA, Dosne Pasqualini C and Charrau EH. (1989). Int. J. Cancer, 43, 845-850.
22. Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD and Sliwkowski MX. (1996). Cancer Res., 56, 1457-1465.
23. Lowe WL, Fu R and Banko M. (1997). Endocrinology, 138, 2219-2226.
24. Lupu R and Lippman ME. (1993). Breast Cancer Res. Treat., 27, 83-93.
25. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE and Taverna D. (1995a). Oncogene, 10, 167-175.
26. Marte BB, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y and Hynes N. (1995b). Mol. Endocrinol., 9, 14-23.
27. Molinolo AA, Lanari C, Charreau EH, San Juan N and Dosne Pasqualini C. (1987). J. Natl. Cancer Inst., 79, 1341-1350.
28. Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Colletta G, Ciardello F and Salomon D. (1995). Breast Cancer Res. Treat., 35, 293-297.
29. Normanno N, Qi C, Gullik WJ, Persico MG, Yarden Y, Wen D, Plowman GD, Kenney N, Johnson GR, Kim N, Brandt R, Martinez-Lacaci I, Dickson RB and Salomon DS. (1993). Int. J. Oncol., 2, 903-911.
30. Peles E and Yarden Y. (1993). Bio Essays, 15, 815-824.
31. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Odgen SG, Ben Levy R and Yarden Y. (1992). Cell, 69, 205-216.
32. Pietras RJ, Arboleda J, Reese DM, Wongpivat N, Pegram MD, Ramos L, Gorman CM, Parker M, Sliwkowski MX and Slamon D. (1995). Oncogene, 10, 2435-2446.
33. Pinkas-Kramarski R, Alroy I and Yarden Y. (1997). J. Mam. Gland Biol. Neoplasia, 2, 97-107.
34. Ram TG, Kokeny KE, Dilts CA and Ethier SP. (1995). J. Cell. Physiol., 163, 589-596.
35. Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R and Martin MB. (1996). Endocrinology, 137, 4322-4330.
36. Scatchard G. (1949). Ann. NY Acad. Sci., 51, 660-672.
37. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, De Angelis T, Rubin R, Efstratiadis A and Baserga R. (1994). Mol. Cell. Biol., 14, 3604-3612.
38. Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupu R. (1996). Oncogene, 12, 1679-1687.
39. Tang C, Perez C, Grunt T, Waibel C, Cho C and Lupu R. (1996). Cancer Res., 56, 3350-3358.
40. Wen D, Suggs V, Karunagaran D, Liyu R, Cupples L, Luo Y, Jansen AM, Ben Barush N, Trolinger DB, Jacobson VL, Meng T, Lu HS, Hu S, Chang D, Yanigahara D, Koski RA and Yarden Y. (1994). Mol. Cell. Biol., 14, 1909-1919.
41. Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Ben Levy R, Koski RA, Lu HS and Yarden Y. (1992). Cell, 69, 559-572.
42. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C and Birchmeier WJ. (1995). J. Cell. Biol., 131, 215-226.
43. Young JAT and Trowsdale J. (1985). Nucl. Acids Res., 13, 8883-8891.